Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS

https://doi.org/10.17749/2070-4909.2016.9.2.045-048

Full Text:

Abstract

Objective. To determine the priority used to vital drugs in сhronic obstructive pulmonary disease (COPD) patients in hospitals of the Kirov region.

Materials and Methods. We analyzed 143 medical records of the patient, the analysis of cost of illness, ABC\ VEN — analysis.

Results. The results of АВС analysis show that the percentage correlation of medicines of different groups generally corresponds to the recommended norm. The results of VEN analysis prove that the number of vital drugs is decreased while the number of second line drugs is increased.

Conclusion. Most of the financial costs were for the treatment of exacerbations of COPD, the appropriate Federal clinical guidelines, simultaneously, there is an active assignment of the second line drugs. Reducing their use and rational therapy of acute conditions will enable competently reallocate financial resources in favour of vital drugs to increase the effectiveness of treatment and reduce the cost of inpatient care.

About the Authors

E. E. Vidyakina
Kirov city hospital №4
Russian Federation

Chief Physician;

Head Part-Time Therapist of the Kirov region Health Ministry,

ul. Verchosunskaya, 8, Kirov, 610002



S. V. Malchikova
Kirov State Medical Academy
Russian Federation

MD, Professor of the Department of Hospital Therapy,

ul. Karla Marksa, 112, Kirov, 610027



References

1. Avdeev S. N. Spravochnik poliklinicheskogo vracha. 2009; 11: 27-31.

2. Avksent’eva M. V., Vorob’ev P. A., Gerasimov I. B., Gorokhova S. G. Problemy standartizatsii v zdravookhranenii. 2000; 4: 42-54.

3. Avksent'eva M. V., Sura M. V. Glavvrach. 2011; 2: 28.

4. Vorob'ev P. A., Avksent'eva M. V., Yur'ev A. S. Clinical and economic analysis [Kliniko-ekonomicheskii analiz (in Russian)]. Moscow. 2008.

5. Denisov I. N. Clinical guidelines based on evidence-based medicine. Trans. from English. / Ed. IN Denisov and others [Klinicheskie rekomendatsii, osnovannye na dokazatel'noi meditsine. Per. s angl. / Pod red. I. N. Denisova i dr. (in Russian)]. Moscow. 2001; 1248 s.

6. Ignat'ev V. A., Titova O. N., Gul'tyaeva O. I. Vestnik SanktPeterburgskogo universiteta. 2007; 4: 37-46.

7. Nurgozhin T. S., Vedernikova O. O., Kuchaeva A. V. i dr. Klinicheskaya farmakologiya i terapiya. 2004; 5; 27-29.

8. Pavlishchuk S. A., Labintseva N. V., Shul'zhenko L. V., Zaburdyaeva Yu. G. Pul'monologiya. 2013; 2: 85-88.

9. Khveshchuk P. F. Evidence-based pharmacotherapy / PF Hveschuk, AV Rudakova [Osnovy dokazatel'noi farmakoterapii / P. F. Khveshchuk, A. V. Rudakova (in Russian)]. SPb. 2000; 235 s.

10. Chelenkova I. N., Uteshev D. B., Bunyatyan N. D. Spravochnik poliklinicheskogo vracha. 2013; 9: 84-87.

11. Halbert R. J., Natoli J. L., Gano A. et al. Global burden of COPD: systematic review and meta-analysis. Eur. Respir. J. 2006; 28: 523-532.


For citation:


Vidyakina E.E., Malchikova S.V. PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2016;9(2):45-48. (In Russ.) https://doi.org/10.17749/2070-4909.2016.9.2.045-048

Views: 358


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)